Satellos Bioscience Inc. Opens the Market
Satellos Bioscience Inc. Opens the Market
TORONTO, May 15, 2024 /PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.
多伦多，2024年5月15日 /PRNewswire/-Satellos Bioscience Inc.（多伦多证券交易所股票代码：MSCL）（“Satellos” 或 “公司”）联合创始人兼首席执行官弗兰克·格里森及其团队与多伦多证券交易所（TSX）全球创新板块董事总经理丹尼·利普金一起开放市场并庆祝公司毕业于多伦多证券交易所。
Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit .
Satellos 是一家上市生物技术公司，致力于开发治疗退行性肌肉疾病的改善生活的药物。欲了解更多信息，请访问。
CNW sponsored announcement. To learn more visit .
CNW 赞助的公告。要了解更多信息，请访问。
SOURCE Toronto Stock Exchange
来源：多伦多证券交易所